Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Impact of the Novel Alzheimer's Blood-based Biomarkers: the PLASMAR Study

NCT06246019 is registered in ClinicalTrials.gov with Hospital del Mar Research Institute (IMIM) as lead sponsor.

NCT NCT06246019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06246019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Impact of the Novel Alzheimer's Blood-based Biomarkers: the PLASMAR Study
Lead sponsor
Hospital del Mar Research Institute (IMIM)
Phase
Observational
Overall status
Unknown status
Start date
February 7, 2024
Completion date
December 31, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive impairment, dementia, frontotemporal dementia, lewy body disease, neurodegenerative diseases, vascular dementia